Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis?

Journal of Laboratory and Clinical Medicine

Volumn 132, Issue 4, 1998, Pages 329-340

  Douma, Caroline E ^a   De Waart, Dirk R ^b   Struijk, Dirk G ^b   Krediet, Raymond T ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIC GMP; NITRIC OXIDE; PHOSPHOLIPASE A; PROSTAGLANDIN E2;

ADULT; ARTICLE; BLOOD; BLOOD FLOW VELOCITY; COMPARATIVE STUDY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; HUMAN; KIDNEY DISEASE; MALE; METABOLISM; MIDDLE AGED; PERITONEUM; PERITONITIS; PERMEABILITY; PHYSIOLOGY; SPLANCHNIC BLOOD FLOW; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; BIOLOGICAL TRANSPORT; BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; CYCLIC GMP; DINOPROSTONE; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; NITRIC OXIDE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; PERITONITIS; PERMEABILITY; PHOSPHOLIPASES A; SPLANCHNIC CIRCULATION;

EID: 0031595515     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90047-6     Document Type: Article

References (61)

1. Rubin J, McFarland S, Hellems EW, Bower JD. Peritoneal dialysis during peritonitis. Kidney Int 1981;19:460-4.
2. Rubin J, Ray R, Barnes T, Bower J. Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis. Nephron 1981;29:124-7.
3. Raja RM, Kramer MS, Barber K. Solute transport and ultrafiltration during peritonitis in CAPD patients. ASAIO J 1984;7:8-11.
4. Krediet RT, Zuyderhoudt FMJ, Boeschoten EW, Arisz L. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Eur J Clin Invest 1987;17:43-52.
5. Zemel D, Koomen GCM, Hart AAM, ten Berge RJM, Struijk DG, Krediet RT. Relationship of TNF-α, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993;122:686-96.
6. Steinhauer HB, Schollmeyer P. Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis. Kidney Int 1986;29:584-90.
7. Goldman M, Vandenabeele P, Moulart J, Amraoui Z, Abramowicz D, Nortier J, Vanderweghem J-L, Fiers W. Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis. Nephron 1990;56:277-80.
8. Zemel D, Krediet RT, Koomen GCM, Kortekaas WMR, Geertzen HGM, ten Berge RJM. Interleukin-8 during peritonitis in patients treated with CAPD: an in vivo model of acute inflammation. Nephrol Dial Transplant 1994;9:169-74.
9. Pernas P, Masliah J, Olivier J-L, Salvat C, Rybkine T, Bereziat G. Type II phospholipase A2 recombinant overexpression enhances stimulated arachidonic acid release. Biochem Biophys Res Commun 1991;178:1298-305.
10. 2 enzymes: regulation and inhibition. Trends Pharmacol Sci 1993;14:92-8.
11. Vadas P, Pruzanski W, Stefanski E, Johnson L, Seilhamer J, Mustard R Jr, et al. Phospholipases A2 in acute bacterial peritonitis in man. In: Dennis EA, Hunter T, Berridge M, editors. Cell activation and signal initiation. New York: Alan R Liss; 1989, p. 311-6.
12. Jassal SV, Morton AR, Vadas P, Pruzanski W, Stefanski E, Pierratos A. Pro-inflammatory activity of phospholipase A2 in CAPD patients with and without peritonitis. Perit Dial Int 1997;17:197-9.
13. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res 1990;66:1561-75.
14. Douma CE, de Waart DR, Zemel D, Imholz ALT, Struijk DG, Krediet RT. Nitrate in stable CAPD patients and during peritonitis. Adv Perit Dial 1995;11:36-40.
15. Teale DM, Atkinson AM. Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 1992;30:839-42.
16. Boughton-Smith NK, Ghelani A. Role of induced nitric oxide synthase and increased NO levels in zymosan peritonitis in the rat. Inflamm Res 1995;44(suppl 2):S149-50.
17. Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ. Relationship between cyclic guanosine 3,5-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrate and nitrate oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther 1981;219:181-6.
18. Douma CE, de Waart DR, Struijk DG, Krediet RT. The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD. Kidney Int 1997;51:1885-92.
19. Douma CE, Hiralall JK, de Waart DR, Struijk DG, Krediet RT. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Kidney Int 1998;53:1014-21.
20. Pannekeet MM, Imholz ALT, Struijk DG, Koomen GCM, Langedijk MJ, Scheuten N, et al. The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 1995;48:866-75.
21. Vas SI. Microbiologic aspects of chronic ambulatory peritoneal dialysis. Kidney Int 1983;23:83-92.
22. Boeschoten EW, Rietra PGGM, Krediet RT, Visser MJ, Arisz L. CAPD peritonitis: a prospective randomized trial of oral versus intraperitoneal treatment with cephradine. J Antimicrob Chemother 1985;16:789-97.
23. Krediet RT, Struijk DG, Koomen GCM, Arisz L. Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70. ASAIO Trans 1991;37:662-7.
24. Nolph KD, Popovich RP, Ghods AJ, Twardowski Z. Determinants of low clearances of small solutes during peritoneal dialysis. Kidney Int 1978;13:117-23.
25. Renck H, Ljungström HG, Hedin H, Richter W. Prevention of dextran induced anaphylactic reaction by hapteen inhibition. Acta Chir Scand 1983;149:355-60.
26. Grzegorzewska AE, Moore HL, Nolph KD, Chen TW. Ultra-filtration and effective peritoneal blood flow during peritoneal dialysis in the rat. Kidney Int 1991;39:608-17.
27. Grzegorzewska AE, Antoniewicz K. An indirect estimation of effective peritoneal capillary blood flow in peritoneally dialyzed uremic patients. Perit Dial Int 1992;13(suppl 2):S39-40.
28. Douma CE, de Waart DR, Struijk DG, Krediet RT. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide? Clin Nephrol 1996;45:295-302.
29. McGuire EAH, Helderman JH, Tobin JD, Andres R. Berman M. Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 1976;41:565-73.
30. 2, pH and lactate from arterialized venous blood. J Appl Physiol 1972;32:134-7.
31. Koomen GCM, Krediet RT, Leegwater ACJ, Struijk DG, Arisz L, Hoek FJ. A fast reliable method for the measurement of intraperitoneal dextran 70, used to calculate lymphatic absorption. Adv Perit Dial 1991;7:10-4.
32. 2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol 1992;31:175-8.
33. 2. Cancer Immunol Immunother 1995;41:287-92.
34. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982;126:131-8.
35. Marzinzig M, Nussler AK, Stadler J, Marzinzig E, Barthlen W, Nussler NC, et al. Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiol. Nitric Oxide: Biology and Chemistry. 1997;1:177-89.
36. Thomas CMG, van den Berg RJ, de Koning Gans HJ, Lequin RM. Radioimmunoassays for prostaglandins. II. Measurement of prostaglandin E2 and the 13,14-dihydro-15-keto metabolites of the E and F series. Description of a reliable technique with a universal applicability. Prostaglandins 1978;15:849-55.
37. Waniewski J, Werynski A, Heimbürger O, Lindholm B. Simple models for description of small-solute transport in peritoneal dialysis. Blood Purif 1991;9:129-41.
38. Waniewski J, Heimbürger O, Werynski A, Lindholm B. Aqueous solute concentrations and evaluation of mass transport coefficients in peritoneal dialysis. Nephrol Dial Transplant 1992;7:50-6.
39. Garred LJ, Canaud B, Farrell PC. A simple kinetic model for assessing peritoneal mass transfer in chronic ambulatory peritoneal dialysis. ASAIO J 1983;6:131-7.
40. Imholz ALT, Koomen GCM, Struijk DG, Arisz L, Krediet RT. Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. Kidney Int 1993;43:1339-46.
41. Zemel D, Krediet RT, Koomen GCM, Struijk DG, Arisz L. Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD. Perit Dial Int 1991;11:217-33.
42. Krediet RT, Zemel D, Imholz ALT, Struijk DG. Impact of surface area and permeability on solute clearances. Perit Dial Int 1994;14(suppl 3):S70-7.
43. Canaud B, Liendo-Liendo C, Claret G, Mion H, Mion C. Etude "in situ" de la cinétique de l'ultrafiltration en course de dialyse péritonéale avec périodes de diffusion prolongée. Néphrologie 1980;1:126-30.
44. Rubin J, Nolph KD, Popovich RP, Moncrief JW, Prowant B. Drainage volumes during continuous ambulatory peritoneal dialysis. ASAIO J 1979;2:54-60.
45. Heimbürger O, Waniewski J, Werynski A, Lindholm B. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992;41:1320-32.
46. Altman DG, Bland MJ. Measurement in medicine: the analysis of method comparing studies. Statistician 1983;32:307-17.
47. Bland MJ, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
48. Reddingius RE, Schröder CH, Daha MR, Willems JL, Koster AM, Monnens LAH. Complement in serum and dialysate in children on continuous ambulatory peritoneal dialysis. Perit Dial Int 1995;15:49-53.
49. Krediet RT, Arisz L. Fluid and solute transport across the peritoneum during continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989;9:15-25.
50. Gokal R, Mistry CD, Peers E, and the MIDAS Study Group. A United Kingdom multicenter study of icodextrin in continuous ambulatory peritoneal dialysis. Perit Dial Int 1994;14(suppl 2):S22-7.
51. Rodela H, Yuan Z-Y, Hay JB, Oreopoulos DG, Johnston MG. Reduced lymphatic drainage of dialysate from the peritoneal cavity during acute peritonitis in sheep. Perit Dial Int 1996;16:163-71.
52. 2 and demonstration of postoperative elevation. Enzyme 1991;45:200-8.
53. 2 by resident mouse peritoneal macrophages. Biochem J 1981;200:441-4.
54. 2 activity of lysosomal origin secreted by polymorphonuclear leucocytes during phagocytosis or on treatment with calcium. Biochim Biophys Acta 1981;665:571-7.
55. 2 activity in peritoneal cavity of caseintreated rats. J Biochem 1986;100:1099-101.
56. 2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock. J Lab Clin Med 1984;104:873-81.
57. 2 in human volunteers challenged with intravenous endotoxin. Inflammation 1992;16:561-70.
58. Pannekeet MM, Zemel D, Koomen GCM, Struijk DG, Krediet RT. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD. Perit Dial Int 1995;15:217-25.
59. Davenport A, Fernando R, Varghese Z. Does the human peritoneal membrane produce nitric oxide (NO)[abstract]? J Am Soc Nephrol 1996;7:1426.
60. Yang CW, Hwang TL, Wu CH, Wu MS, Lai PC, Huang JY, et al. Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1996;11:2466-71.
61. Zemel D, Struijk DG, Dinkla C, Stolk LM, ten Berge RJM, Krediet RT. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in CAPD. J Lab Clin Med 1995;126:204-15.